Bridging the Gap from Research to Reality!

About Us

Sanammad Pharmaceuticals, BV is the pharma and biotech arm of Sanammad Foundation and Sanammad USA.  The partners within the company started collaboration in 2002 and developed the first in the world, patented, transmucosal, controlled release, functional delivery system containing cannabinoids.  This system is the first to recognize and implement the act of mastication as a neuroprotective mechanism in a pharmaceutical formulation and thus create products where the effects of the API’ are augmented by the physiological act of chewing.

The partners have extensive experience in the health sciences, in innovative technologies and have created numerous unique IP’ covering a broad range of bioscience disciplines.  Two of the principals are nationally and internationally recognized craniofacial surgeon sand academicians, and the third partner has vast experience in medicinal chemistry, designer drugs, consumer products development and IP procurement.  All three are seasoned entrepreneurs and board members of public traded and private companies.  The management has excellent contacts throughout the biotechnology domain both nationally and internationally and maintains close cooperation with numerous regulatory organizations involved with licensing and registration of healthcare products.

We possess solid in-house expertise in designing and running clinical trials we are supported by dedicated advisers with extensive expertise in Pharmaceutical and Consumer products development and key opinion leaders in their respective fields.